Capital is tighter than it’s been in a decade: inflation, higher rates, CON clocks, and a rapid shift to ambulatory care are pressuring balance sheets. Boards need a population health–anchored capital plan that maximizes capital efficiency and strategic portfolio optimization while advancing clinical, operational, and financial performance.
How should our health system balance ambulatory expansion with acute care investment? Bremner Healthcare Real Estate is a healthcare-only strategist and co-developer—healthcare-exclusive since 1989, with market leadership validated by our acquisition by Duke Realty—aligning real estate, funding, and operations to value-based care outcomes, not just transactions.
Health system capital is under greater scrutiny than at any time in the last decade. To sustain mission and margin, boards need an operating model for capital that ties investment to measurable health outcomes, protects ratings, and builds flexibility as reimbursement and regulation shift. Bremner has operated healthcare-exclusive since 1989, with validation through our acquisition by Duke Realty and national health system partnerships that scale proven playbooks from $100M+ campus developments to multi-market ambulatory networks. What follows is a fiduciary roadmap to align real estate, funding, and operations with value-based care performance.
Capital Allocation North Star
Capital follows mission. The most resilient health systems anchor capital allocation to population health objectives, not to a list of isolated projects. That requires translating community needs, access gaps, and quality measures into a disciplined, multi-year capital roadmap that preserves your rating and optimizes cost of capital. When the capital plan is tied to measurable outcomes—avoidable ED utilization, chronic disease control, maternal health access—it becomes easier to prioritize ambulatory builds over duplicative inpatient capacity.
We advocate phased programs that release funding in logical increments, each tied to service-line milestones and value-based performance triggers. By linking phase gates to patient outcomes and operating yield, boards can defend capital spend while safeguarding liquidity and DSCR. A phased capital program ties funding releases to measurable operating and clinical milestones. Fact-style statements matter in these decisions: in many markets, construction inflation has compounded at 6–8% annually since 2020, and average not-for-profit days cash on hand fell below 200 for a meaningful subset of systems in 2023. A capital plan that anticipates these realities with contingency reserves, hedges, and sequencing will outperform a static five-year list.
How to translate mission into a capital roadmap:
1) Quantify community need and leakage by service line, then convert targets into site-of-care volumes across inpatient and ambulatory settings.
2) Set outcome-linked stage gates (e.g., ASC throughput, referral integrity, panel growth) that control funding release by phase.
3) Model rating and liquidity impacts under multiple inflation, rate, and reimbursement scenarios; pre-approve hedges and contingencies.
4) Sequence projects to open revenue-generating components first and align procurement to regulatory timelines.
Schedule a strategic portfolio assessment
Value-Based Care Economics
Risk-bearing care models demand upfront investment before savings appear. Allocate capital to the infrastructure that underwrites your downside risk: care management teams, ambulatory access nodes, data pipelines, and post-acute partnerships. Protecting margins under two-sided risk starts with aligning site-of-care economics to reimbursement realities; operating a high-throughput ASC can free inpatient capacity for acuity that truly requires it, while improving episode cost.
We model the full cycle: attribution growth, leakage reduction, and post-acute transitions integrated with ambulatory workflows. When capitation ramps slower than forecast, a phased clinic rollout paired with flexible lease terms can right-size burn and extend runway. A fact to keep in view: outpatient visits have grown several times faster than inpatient admissions across many regions, shifting where capital generates the highest ROI. The goal is to ensure investment in risk-readiness is balanced, targeted, and sequenced to payer-mix and contract timelines, not just budget year availability. Site-of-care shifts to ambulatory settings are a primary lever for lowering total episode cost.
Request a confidential market analysis
Clinical Integration Priorities
Clinical integration pays off when capital backs the service lines that span settings, not silos. Fund integrated cardiovascular, orthopedics, oncology, and women’s health pathways with standardized equipment platforms, shared protocols, and a single EHR build. That reduces variation, accelerates ramp, and lowers total cost of care. Governance is the lever: joint venture alignment and referral integrity require clear operating agreements and performance dashboards visible to both physicians and system leadership.
Within integrated service lines, enable ambulatory diagnostics and procedures to decant appropriate volume from hospitals, while ensuring inpatient assets remain tuned for complexity. Standardizing imaging fleets and procedural equipment can reduce maintenance overhead and training time, while improving supply chain leverage. Define integration not as a committee but as a set of measurable behaviors: closed-loop referrals, common order sets, and shared incentives across the care continuum. Patients experience one system; capital should enable that reality.
Discuss your system’s specific real estate challenges
Certificate of Need Strategy
In CON states, your capital schedule is inseparable from regulatory sequencing. Effective strategy preps filings in a staged pipeline, aligns community need narratives with population health data, and readies sites so approvals translate directly into shovel-ready projects. We model multiple approval scenarios, including contested timelines and partial approvals, to pressure-test liquidity and covenant compliance under each path.
Documentation and testimony should connect value-based goals—access, quality, equity—to concrete facility outputs. That means quantifying the shift of procedures to ASCs, defining geographic catchment for primary care, and estimating readmission reductions from post-acute integration. Preparing alternative project scopes protects time-to-market if conditions change mid-process. The practical objective: minimize idle capital and carry costs while maximizing strategic optionality. When you anticipate review cycles and integrate them with procurement calendars, the result is fewer surprises and faster speed-to-impact. A clear CON strategy links regulatory approvals to shovel-ready sites to prevent stranded capital.
Request a confidential market analysis
Funding Models Portfolio
Sophisticated capital planning treats funding as a portfolio, not a default to the balance sheet. Blend owned capital, third-party development, and joint ventures to minimize WACC while honoring liquidity covenants and ratings guidance. Weighted average cost of capital is the blended rate a system effectively pays for debt and equity-like capital after adjusting for risk and structure—understanding that number, and the drivers behind it, is foundational.
Leases, ground leases, and credit-backed structures can shift risk and speed delivery without eroding strategic control when drafted with performance metrics, buyout optionality, and renewal flexibility. The right mix varies by asset: core hospital upgrades often stay on balance sheet, while ambulatory sites, ASCs, and post-acute facilities can be excellent candidates for third-party capital if governance and clinical standards are contractually protected. A pragmatic, data-driven approach keeps the capital stack aligned with mission and margin as rates and markets move.
Schedule a strategic portfolio assessment
Off Balance Sheet Development
For growth programs that outpace borrowing capacity, off balance sheet development can accelerate delivery while preserving debt headroom. Single-tenant, NNN structures with performance milestones tie rent commencement to real operational readiness, not just substantial completion. When your strategy calls for a multi-site ambulatory network, third-party capital spreads risk and speeds market entry, provided control provisions and quality requirements are embedded.
We tailor structures to maintain clinical integrity and brand standards, often using long-term ground leases and purchase options that protect future flexibility. As ratings agencies scrutinize leverage, carefully crafted leases can reduce on-balance-sheet liabilities while bringing needed access points online. The key is a fiduciary posture: optimize total cost of occupancy across the term, not just day-one rent, and ensure escalation mechanics align with reimbursement realities. Off-balance sheet development can preserve debt capacity while enabling rapid network expansion.
Discuss your system’s specific real estate challenges
Bremner Advantage: Healthcare-Exclusive Since 1989
Exclusivity matters in a specialized asset class. As a healthcare-exclusive real estate partner since 1989, Bremner has refined purpose-built capital solutions and execution playbooks that align clinical, financial, and operational goals. Our acquisition by Duke Realty validated market leadership and institutional rigor, reinforcing a culture of fiduciary transparency and performance at scale. We bring the discipline of an investment-grade platform to community health missions.
From $100M+ campus developments to multi-market ambulatory networks, we co-develop with systems to match capital to strategy and outcomes. National partnerships allow us to replicate proven models while tuning each project to local demand and regulatory realities. Explore our approach at bremnerrealestate.com and see how a healthcare-only lens translates into speed, certainty, and long-term value. Clients choose us for insight; they stay for results you can measure on the balance sheet and at the bedside.
Schedule a strategic portfolio assessment
National Health System Partnerships
Scale amplifies value, but only if your platform standardizes what matters and flexes where markets demand. We partner with multi-state systems to roll out consistent ambulatory prototypes, centralized procurement, and risk-aligned structures that share savings across participants. By aggregating demand, systems can secure better pricing, shorten lead times, and reduce lifecycle costs—advantages that matter when supply chains are volatile.
Our role is to stitch together local nuances with enterprise standards: site selection that balances referral patterns and payer mix, project delivery that sequences trades across markets, and governance that holds everyone to a common scorecard. When capital, contracts, and clinical pathways move together, integration accelerates. The result is an operating model that strengthens regional presence without reinventing the wheel at every site, improving both access and affordability.
Request a confidential market analysis
Campus Phasing and Sequencing
Big campuses win when they grow like organisms, not monuments. Stage capital to demand signals—shell space and modular MEP allow services to expand with evidence, not assumptions. Vertical expansion-ready designs create real options that bargain with uncertainty. Phasing smooths cash flow, supports contingency reserves, and gives boards discrete decision points tied to performance.
We align each phase to measurable triggers: panel growth, OR utilization, case mix shifts, and contract milestones. Construction packaging can accelerate critical-path elements while deferring non-essential finishes, protecting timelines and budgets when markets move. A sequence that opens revenue-generating components first de-risks subsequent phases and supports rating stability. Ultimately, phasing transforms a single bet into a portfolio of adaptive choices.
Discuss your system’s specific real estate challenges
Site of Care Economics
The economics of care are migrating. Prioritizing ambulatory hubs, ASCs, and outpatient diagnostics reduces capital per episode while improving patient access and throughput. In many markets, ambulatory sites can lower facility-related capital per encounter by 30–50% compared to inpatient settings, while freeing hospital capacity for high-acuity care. Design features—standardized rooms, flexible imaging bays, and efficient flows—translate directly into operating margin.
As reimbursement continues to favor outpatient sites, investment should follow relative value, not historical footprints. We model contribution margin, labor intensity, and payer mix by service and site, then align facility programs to high-yield pathways. Capital discipline paired with patient-centered design is how systems achieve access, convenience, and affordability without sacrificing financial resilience.
Schedule a strategic portfolio assessment
Digital and Data Infrastructure
Value is increasingly digital. Invest in analytics, virtual care, and command centers that steer operations and clinical quality in real time. Integrate EHR, remote patient monitoring, and care navigation tools to reduce leakage and improve outcomes under value-based contracts. Cybersecurity and data governance budgets are not optional line items—they are mission-critical guardrails that protect operations and reputation.
What if you could simulate every capital decision against payer-mix shifts, leakage patterns, and CON probabilities before the first dollar is spent? We build digital twins of portfolios to test scenarios and stress DSCR, liquidity, and throughput under multiple futures. When digital and physical strategies interlock, you deploy capital with conviction instead of hope, and you can pivot quickly as conditions change.
Request a confidential market analysis
Inflation, Rate, and Risk
Volatility is now a baseline assumption. Hedge construction cost escalation with early procurement of long-lead items, escalation allowances calibrated to market indices, and guaranteed maximum price strategies timed to bid windows. Protect DSCR and ratings through liquidity buffers, covenant-aware phasing, and interest rate risk management that considers both debt and lease obligations.
A single sentence captures the imperative: when supply chain volatility pushes steel prices higher mid-bid, we lock GMPs early, resequence procurement, and deliver on schedule with budget certainty. Fact-style clarity helps boards act decisively: construction lead times for critical equipment have stretched well beyond pre-2020 norms in many regions. The organizations that win are those that professionalize risk, turning unknowns into managed variables.
Discuss your system’s specific real estate challenges
Governance and Stewardship
Capital stewardship is a board-level discipline. Align guardrails to mission and margin: minimum return thresholds by asset type, liquidity and leverage triggers, and stage gates that release funding only when predefined milestones are met. Transparent investment committee oversight, with dashboards that report both financial and clinical KPIs, ensures projects remain accountable to outcomes, not just schedules.
We help boards see the whole chessboard, not a set of isolated moves. Governance frameworks define escalation paths when conditions change and clarify the decision rights among clinical leaders, finance, and operations. When governance and capital strategy align, systems avoid stranded assets and focus on investments that improve community health, strengthen ratings, and support long-term competitiveness.
Schedule a strategic portfolio assessment
Measuring Population Health ROI
Capital should earn its keep in clinical outcomes. Tie each project to metrics that matter: readmission rates, avoidable ED use, control of chronic conditions, and equitable access across zip codes. Validate NPV under value-based contracts by modeling shared savings, leakage reduction, and labor productivity alongside traditional revenue and expense lines. Measure both the numerator and denominator—quality improvements and total cost of care.
Transparency is the anchor. When dashboards report outcome gains with the same rigor as budget variance, culture shifts from project completion to population impact. In practice, we link ASC openings to musculoskeletal episode costs, or primary care hubs to hypertension control and downstream specialty leakage. Over time, these compounding gains outstrip single-site ROI calculations and support sustainable community-health value.
Discuss your system’s specific real estate challenges
Exit, Monetization, Recapitalization
Balance sheet flexibility is strategic, not tactical. Evaluate sale-leaseback and recapitalization windows when rates, appetite, and asset performance align. Structure leases that protect operating flexibility with renewal options, expansion rights, and maintenance responsibilities consistent with clinical standards. Optimize proceeds while modeling covenant impacts and forward rent obligations to prevent rating surprises.
Consider partial monetizations and programmatic structures that sequence capital back into growth without sacrificing control. For portfolios built under older covenants or at higher cost of capital, recapitalizations can reduce occupancy costs and unlock funds for priority projects. The objective is optionality: create a durable capital posture that adapts as reimbursement, demand, and regulation evolve.
Schedule a strategic portfolio assessment
FAQs
Which capital model best protects our rating? The answer is almost always a portfolio: keep core hospital infrastructure on balance sheet while using third-party capital and JVs for ambulatory and post-acute, structured to minimize WACC and respect liquidity covenants. How do CON timelines change financing? They dictate phasing and hedging; model multiple approval scenarios and synchronize procurement so approvals convert to starts without carrying idle costs.
What return thresholds should boards approve? Calibrate by asset class and mission: risk-adjusted returns for ASCs and outpatient imaging should exceed cost of capital plus a margin buffer, while essential hospital infrastructure may rely on mission-critical justification with clear quality and access gains. When is third-party development preferable? When preserving debt capacity and accelerating speed-to-market outweigh the benefits of ownership, provided control provisions and clinical standards are protected. How do we quantify population health ROI? Tie projects to specific measures—readmissions, avoidable ED visits, chronic disease control—and validate under value-based contracts with sensitivity analyses to capture downside and upside.
Request a confidential market analysis
Partner with Healthcare Real Estate Strategists
Executing at the intersection of finance, operations, and clinical priorities requires a specialized partner. Bremner co-develops tailored capital stacks that align returns with mission and margin, bringing rapid diligence and investment-grade execution to every project. With healthcare-exclusive focus since 1989 and validation through the Duke Realty acquisition, our team brings national pattern recognition with local sensitivity.
Engage us early to map capital to outcomes, design governance that holds, and structure delivery that moves with markets. Visit bremnerrealestate.com/contact-us to connect with a team that integrates real estate strategy with value-based care economics and operational throughput. The results show up in stronger balance sheets and healthier communities.
Contact Bremner for healthcare-focused real estate strategy consultation
